Medicofarma Biotech SA
WSE:MDB
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.432
1.225
|
Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MDB stock under the Base Case scenario is 0.099 PLN. Compared to the current market price of 0.484 PLN, Medicofarma Biotech SA is Overvalued by 80%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Medicofarma Biotech SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MDB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Medicofarma Biotech SA
Balance Sheet Decomposition
Medicofarma Biotech SA
Current Assets | 2.9m |
Cash & Short-Term Investments | 59.9k |
Receivables | 464.8k |
Other Current Assets | 2.4m |
Non-Current Assets | 12.7m |
PP&E | 11.7m |
Intangibles | 958.2k |
Other Non-Current Assets | -10 |
Current Liabilities | 3.6m |
Accounts Payable | 2.2m |
Accrued Liabilities | 1.3m |
Other Current Liabilities | 182k |
Non-Current Liabilities | 2.1m |
Other Non-Current Liabilities | 2.1m |
Earnings Waterfall
Medicofarma Biotech SA
Revenue
|
1.4m
PLN
|
Cost of Revenue
|
-195.6k
PLN
|
Gross Profit
|
1.2m
PLN
|
Operating Expenses
|
-2.2m
PLN
|
Operating Income
|
-1m
PLN
|
Other Expenses
|
-33k
PLN
|
Net Income
|
-1.1m
PLN
|
Free Cash Flow Analysis
Medicofarma Biotech SA
PLN | |
Free Cash Flow | PLN |
MDB Profitability Score
Profitability Due Diligence
Medicofarma Biotech SA's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
Medicofarma Biotech SA's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
MDB Solvency Score
Solvency Due Diligence
Medicofarma Biotech SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Medicofarma Biotech SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MDB Price Targets Summary
Medicofarma Biotech SA
Dividends
Current shareholder yield for MDB is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.
Contact
IPO
Employees
Officers
The intrinsic value of one MDB stock under the Base Case scenario is 0.099 PLN.
Compared to the current market price of 0.484 PLN, Medicofarma Biotech SA is Overvalued by 80%.